Cargando…

Novel grading system for quantification of cystic macular lesions in Usher syndrome

BACKGROUND: To evaluate novel grading system used to quantify optical coherence tomography (OCT) scans for cystic macular lesions (CML) in Usher syndrome (USH) patients, focusing on CML associated alterations in MOY7A and USH2A mutations. METHODS: Two readers evaluated 76 patients’ (mean age 42 ± 14...

Descripción completa

Detalles Bibliográficos
Autores principales: Sliesoraityte, Ieva, Peto, Tunde, Mohand-Said, Saddek, Sahel, Jose Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676164/
https://www.ncbi.nlm.nih.gov/pubmed/26654877
http://dx.doi.org/10.1186/s13023-015-0372-0
_version_ 1782405125277483008
author Sliesoraityte, Ieva
Peto, Tunde
Mohand-Said, Saddek
Sahel, Jose Alain
author_facet Sliesoraityte, Ieva
Peto, Tunde
Mohand-Said, Saddek
Sahel, Jose Alain
author_sort Sliesoraityte, Ieva
collection PubMed
description BACKGROUND: To evaluate novel grading system used to quantify optical coherence tomography (OCT) scans for cystic macular lesions (CML) in Usher syndrome (USH) patients, focusing on CML associated alterations in MOY7A and USH2A mutations. METHODS: Two readers evaluated 76 patients’ (mean age 42 ± 14 years) data prospectively uploaded on Eurush database. OCT was used to obtain high quality cross-sectional images through the fovea. The CML was graded as none, mild, moderate or severe, depending on the following features set: subretinal fluid without clearly detectable CML boundaries; central macular thickness; largest diameter of CML; calculated mean of all detectable CML; total number of detectable CML; retinal layers affected by CML. Intra-and inter-grader reproducibility was evaluated. RESULTS: CML were observed in 37 % of USH eyes, while 45 % were observed in MYO7A and 29 % in USH2A cases. Of those with CML: 52 % had mild, 22 % had moderate and 26 % had severe changes, respectively. CML were found in following retinal layers: 50 % inner nuclear layer, 44 % outer nuclear layer, 6 % retinal ganglion cell layer. For the inter-grader repeatability analysis, agreements rates for CML were 97 % and kappa statistics was 0.91 (95 % CI 0.83-0.99). For the intra-grader analysis, agreement rates for CML were 98 %, while kappa statistics was 0.96 (95 % CI 0.92-0.99). CONCLUSIONS: The novel grading system is a reproducible tool for grading OCT images in USH complicated by CML, and potentially could be used for objective tracking of macular pathology in clinical therapy trials.
format Online
Article
Text
id pubmed-4676164
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46761642015-12-12 Novel grading system for quantification of cystic macular lesions in Usher syndrome Sliesoraityte, Ieva Peto, Tunde Mohand-Said, Saddek Sahel, Jose Alain Orphanet J Rare Dis Research BACKGROUND: To evaluate novel grading system used to quantify optical coherence tomography (OCT) scans for cystic macular lesions (CML) in Usher syndrome (USH) patients, focusing on CML associated alterations in MOY7A and USH2A mutations. METHODS: Two readers evaluated 76 patients’ (mean age 42 ± 14 years) data prospectively uploaded on Eurush database. OCT was used to obtain high quality cross-sectional images through the fovea. The CML was graded as none, mild, moderate or severe, depending on the following features set: subretinal fluid without clearly detectable CML boundaries; central macular thickness; largest diameter of CML; calculated mean of all detectable CML; total number of detectable CML; retinal layers affected by CML. Intra-and inter-grader reproducibility was evaluated. RESULTS: CML were observed in 37 % of USH eyes, while 45 % were observed in MYO7A and 29 % in USH2A cases. Of those with CML: 52 % had mild, 22 % had moderate and 26 % had severe changes, respectively. CML were found in following retinal layers: 50 % inner nuclear layer, 44 % outer nuclear layer, 6 % retinal ganglion cell layer. For the inter-grader repeatability analysis, agreements rates for CML were 97 % and kappa statistics was 0.91 (95 % CI 0.83-0.99). For the intra-grader analysis, agreement rates for CML were 98 %, while kappa statistics was 0.96 (95 % CI 0.92-0.99). CONCLUSIONS: The novel grading system is a reproducible tool for grading OCT images in USH complicated by CML, and potentially could be used for objective tracking of macular pathology in clinical therapy trials. BioMed Central 2015-12-10 /pmc/articles/PMC4676164/ /pubmed/26654877 http://dx.doi.org/10.1186/s13023-015-0372-0 Text en © Sliesoraityte et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sliesoraityte, Ieva
Peto, Tunde
Mohand-Said, Saddek
Sahel, Jose Alain
Novel grading system for quantification of cystic macular lesions in Usher syndrome
title Novel grading system for quantification of cystic macular lesions in Usher syndrome
title_full Novel grading system for quantification of cystic macular lesions in Usher syndrome
title_fullStr Novel grading system for quantification of cystic macular lesions in Usher syndrome
title_full_unstemmed Novel grading system for quantification of cystic macular lesions in Usher syndrome
title_short Novel grading system for quantification of cystic macular lesions in Usher syndrome
title_sort novel grading system for quantification of cystic macular lesions in usher syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676164/
https://www.ncbi.nlm.nih.gov/pubmed/26654877
http://dx.doi.org/10.1186/s13023-015-0372-0
work_keys_str_mv AT sliesoraityteieva novelgradingsystemforquantificationofcysticmacularlesionsinushersyndrome
AT petotunde novelgradingsystemforquantificationofcysticmacularlesionsinushersyndrome
AT mohandsaidsaddek novelgradingsystemforquantificationofcysticmacularlesionsinushersyndrome
AT saheljosealain novelgradingsystemforquantificationofcysticmacularlesionsinushersyndrome